Literature DB >> 9653117

The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha.

S Miyake1, M L Lupher, B Druker, H Band.   

Abstract

The Cbl protooncogene product has emerged as a negative regulator of receptor and nonreceptor tyrosine kinases. We recently demonstrated that oncogenic Cbl mutants upregulate the endogenous tyrosine kinase signaling machinery when expressed in the NIH 3T3 cells, and identified the platelet-derived growth factor receptor-alpha (PDGFRalpha) as one of the tyrosine kinases targeted by these oncogenes. These findings suggested a role for the normal Cbl protein in negative regulation of the PDGFRalpha. However, the mechanism of such negative regulation remained to be determined. Here we show that overexpression of the wild-type Cbl enhances the ligand-induced ubiquitination of the PDGFRalpha. Concomitantly, the PDGFRalpha in Cbl-overexpressing cells undergoes a faster ligand-induced degradation compared with that in the control cells. These results identify a role for Cbl in the regulation of ligand-induced ubiquitination and degradation of receptor tyrosine kinases and suggest one potential mechanism for evolutionarily conserved negative regulatory influence of Cbl on tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653117      PMCID: PMC20906          DOI: 10.1073/pnas.95.14.7927

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Receptor signalling and the regulation of endocytic membrane transport.

Authors:  M N Seaman; C G Burd; S D Emr
Journal:  Curr Opin Cell Biol       Date:  1996-08       Impact factor: 8.382

2.  F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex.

Authors:  D Skowyra; K L Craig; M Tyers; S J Elledge; J W Harper
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

3.  Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.

Authors:  M Jeffers; G A Taylor; K M Weidner; S Omura; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 4.  Regulating protein degradation by ubiquitination.

Authors:  A M Weissman
Journal:  Immunol Today       Date:  1997-04

5.  The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase.

Authors:  Y Ota; L E Samelson
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

6.  Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.

Authors:  D P Bonita; S Miyake; M L Lupher; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.

Authors:  H Meisner; A Daga; J Buxton; B Fernández; A Chawla; U Banerjee; M P Czech
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

8.  Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation.

Authors:  C E Bazenet; J A Gelderloos; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

9.  Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling.

Authors:  H Ueno; K Sasaki; K Miyagawa; H Honda; K Mitani; Y Yazaki; H Hirai
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

10.  A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells.

Authors:  M L Lupher; K A Reedquist; S Miyake; W Y Langdon; H Band
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

View more
  62 in total

1.  RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.

Authors:  K L Lorick; J P Jensen; S Fang; A M Ong; S Hatakeyama; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Authors:  C E Andoniou; N L Lill; C B Thien; M L Lupher; S Ota; D D Bowtell; R M Scaife; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion.

Authors:  T M Fournier; L Lamorte; C R Maroun; M Lupher; H Band; W Langdon; M Park
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

4.  Self-assembly properties of a model RING domain.

Authors:  Alex Kentsis; Ronald E Gordon; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 5.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

6.  The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation.

Authors:  N Rao; A K Ghosh; S Ota; P Zhou; A L Reddi; K Hakezi; B K Druker; J Wu; H Band
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

7.  The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins.

Authors:  James E Egan; Amy B Hall; Bogdan A Yatsula; Dafna Bar-Sagi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

8.  Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.

Authors:  P van Kerkhof; C M Alves dos Santos; M Sachse; J Klumperman; G Bu; G J Strous
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

9.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

10.  Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.

Authors:  Esther Sook Miin Wong; Chee Wai Fong; Jormay Lim; Permeen Yusoff; Boon Chuan Low; Wallace Y Langdon; Graeme R Guy
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.